Neural tube defects-disorders of neurulation and related embryonic processes

Wiley Interdisciplinary Reviews: Developmental Biology

Volumn 2, Issue 2, 2013, Pages 213-227

  Copp, Andrew J ^a   Greene, Nicholas D E ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BRCA1 PROTEIN; CARBAMAZEPINE; CASPASE 3; CASPASE 9; CYTOCHALASIN; FOLIC ACID; HISTONE DEACETYLASE; INOSITOL; MARCKS PROTEIN; MYOSIN ADENOSINE TRIPHOSPHATASE; PROTEIN P21; PROTEIN P27; PROTEIN PATCHED 1; RETINOIC ACID; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR HES 1; TRANSCRIPTION FACTOR PAX3; TRANSFORMING GROWTH FACTOR BETA; TRICHOSTATIN A; TRIMETHOPRIM; VALPROIC ACID;

ANENCEPHALUS; APOPTOSIS; CELL CYCLE PROGRESSION; CELL PROLIFERATION; COST BENEFIT ANALYSIS; CRANIORACHISCHISIS; CYTOSKELETON; DIET SUPPLEMENTATION; ENVIRONMENTAL FACTOR; EXENCEPHALY; GENE INTERACTION; HUMAN; HYDROCEPHALUS; INIENCEPHALY; LIPOMYELOMENINGOCELE; MECKEL SYNDROME; MENINGOMYELOCELE; NEURAL TUBE DEFECT; NEURULATION; NONHUMAN; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIGNAL TRANDUCTION; SPINAL CORD LESION; SYSTEMATIC REVIEW (TOPIC); VITAMIN DEFICIENCY; ANIMAL; EMBRYO DEVELOPMENT; GENETICS; METABOLISM; MOUSE; PATHOLOGY;

ANENCEPHALY; ANIMALS; BONE MORPHOGENETIC PROTEINS; EMBRYONIC DEVELOPMENT; FOLIC ACID; HEDGEHOG PROTEINS; HUMANS; MENINGOMYELOCELE; MICE; NEURAL TUBE DEFECTS; NEURULATION;

EID: 84879788031     PISSN: 17597684     EISSN: 17597692     Source Type: Journal    
DOI: 10.1002/wdev.71     Document Type: Review

References (76)

1. Dolk H, Loane M, Garne E. The prevalence of congenital anomalies in Europe. Adv Exp Med Biol 2010, 686:349-364.
2. Malcoe LH, Shaw GM, Lammer EJ, Herman AA. The effect of congenital anomalies on mortality risk in white and black infants. Am J Public Health 1999, 89: 887-892.
3. Mitchell LE. Epidemiology of neural tube defects. Am J Med Genet C Semin Med Genet 2005, 135:88-94.
4. Wood LR, Smith MT. Generation of anencephaly: 1. Aberrant neurulation and 2. Conversion of exencephaly to anencephaly. J Neuropath Exp Neurol 1984, 43: 620-633.
5. Seller MJ. Sex, neural tube defects, and multisite closure of the human neural tube. Am J Med Genet 1995, 58: 332-336.
6. Dunlevy LPE, Burren KA, Chitty LS, Copp AJ, Greene NDE. Excess methionine suppresses the methylation cycle and inhibits neural tube closure in mouse embryos. FEBS Lett 2006, 580:2803-2807.
7. Copp AJ, Greene NDE, Murdoch JN. The genetic basis of mammalian neurulation. Nat Rev Genet 2003, 4: 784-793.
8. Copp AJ. Neurulation in the cranial region - normal and abnormal. J Anat 2005, 207:623-635.
9. Van Straaten HWM, Copp AJ. Curly tail: a 50-year history of the mouse spina bifida model. Anat Embryol 2001, 203:225-237.
10. Stiefel D, Shibata T, Meuli M, Duffy P, Copp AJ. Tethering of the spinal cord in mouse fetuses and neonates with spina bifida. J Neurosurg (Spine) 2003, 99:206-213.
11. Harding BN, Copp AJ. Malformations. In: Love S, Louis DN, Ellison DW, eds. Greenfield's Neuropathology. London: Hodder Arnold; 2008, 335-479.
12. Logan CV, Abdel-Hamed Z, Johnson CA. Molecular genetics and pathogenic mechanisms for the severe ciliopathies: insights into neurodevelopment and pathogenesis of neural tube defects. Mol Neurobiol 2010, 43:12-26.
13. Erdincler P, Kaynar MY, Canbaz B, Kocer N, Kuday C, Ciplak N. Iniencephaly: neuroradiological and surgical features. Case report and review of the literature. J Neurosurg 1998, 89:317-320.
14. Leck I. Causation of neural tube defects: clues from epidemiology. Br Med Bull 1974, 30:158-163.
15. Rampersaud E, Melvin EC, Speer MC. Nonsyndromic neural tube defects: genetic basis and genetic investigations. In: Wyszynski DF, ed. Neural Tube Defects: From Origin to Treatment. Oxford: Oxford University Press; 2006, 165-175.
16. Boyles AL, Hammock P, Speer MC. Candidate gene analysis in human neural tube defects. Am J Med Genet C Semin Med Genet 2005, 135:9-23.
17. Greene NDE, Stanier P, Copp AJ. Genetics of human neural tube defects. Hum Mol Genet 2009, 18: R113-R129.
18. Amorim MR, Lima MA, Castilla EE, Orioli IM. Non-latin European descent could be a requirement for association of NTDs and MTHFR variant 677C > T: a meta-analysis. Am J Med Genet A 2007, 143A: 1726-1732.
19. Harris MJ, Juriloff DM. An update to the list of mouse mutants with neural tube closure defects and advances toward a complete genetic perspective of neural tube closure. Birth Defects Res A Clin Mol Teratol 2010, 88:653-669.
20. Davidson CE, Li Q, Churchill GA, Osborne LR, McDermid HE. Modifier locus for exencephaly in Cecr2 mutant mice is syntenic to the 10q25.3 region associated with neural tube defects in humans. Physiol Genomics 2007, 31:244-251.
21. Copp AJ, Brook FA, Estibeiro JP, Shum ASW, Cockroft DL. The embryonic development of mammalian neural tube defects. Prog Neurobiol 1990, 35:363-403.
22. Fleming A, Copp AJ. A genetic risk factor for mouse neural tube defects: defining the embryonic basis. Hum Mol Genet 2000, 9:575-581.
23. Lammer EJ, Sever LE, Oakley GP. Teratogen update: valproic acid. Teratology 1987, 35:465-473.
24. Menegola E, Di RF, Broccia ML, Prudenziati M, Minucci S, Massa V, Giavini E. Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity. Birth Defects Res B Dev Reprod Toxicol 2005, 74:392-398.
25. Gelineau-van WJ, Voss KA, Stevens VL, Speer MC, Riley RT. Maternal fumonisin exposure as a risk factor for neural tube defects. Adv Food Nutr Res 2009, 56: 145-181.
26. Burren KA, Savery D, Massa V, Kok RM, Scott JM, Blom HJ, Copp AJ, Greene NDE. Gene-environment interactions in the causation of neural tube defects: folate deficiency increases susceptibility conferred by loss of Pax3 function. Hum Mol Genet 2008, 17: 3675-3685.
27. Copp AJ, Greene NDE. Genetics and development of neural tube defects. J Pathol 2010, 220:217-230.
28. Greene ND, Massa V, Copp AJ. Understanding the causes and prevention of neural tube defects: insights from the splotch mouse model. Birth Defects Res A Clin Mol Teratol 2009, 85:322-330.
29. Van Straaten HWM, Jansen HCJP, Peeters MCE, Copp AJ, Hekking JWM. Neural tube closure in the chick embryo is multiphasic. Dev Dyn 1996, 207:309-318.
30. O'Rahilly R, Müller F. The two sites of fusion of the neural folds and the two neuropores in the human embryo. Teratology 2002, 65:162-170.
31. Nakatsu T, Uwabe C, Shiota K. Neural tube closure in humans initiates at multiple sites: evidence from human embryos and implications for the pathogenesis of neural tube defects. Anat Embryol 2000, 201:455-466.
32. Sulik KK, Zuker RM, Dehart DB, Cessot F, Delezoide AL, Attié T, Vekemans M. Normal patterns of neural tube closure differ in the human and the mouse. Proc Greenwood Genet Cent 1998, 18:129-130.
33. MacDonald KB, Juriloff DM, Harris MJ. Developmental study of neural tube closure in a mouse stock with a high incidence of exencephaly. Teratology 1989, 39: 195-213.
34. Seller MJ. Neural tube defects and sex ratios. Am J Med Genet 1987, 26:699-707.
35. Harris MJ, Juriloff DM. Mouse mutants with neural tube closure defects and their role in understanding human neural tube defects. Birth Defects Res A Clin Mol Teratol 2007, 79:187-210.
36. Brook FA, Estibeiro JP, Copp AJ. Female predisposition to cranial neural tube defects is not because of a difference between the sexes in rate of embryonic growth or development during neurulation. J Med Genet 1994, 31:383-387.
37. Chen X, Watkins R, Delot E, Reliene R, Schiestl RH, Burgoyne PS, Arnold AP. Sex difference in neural tube defects in p53-null mice is caused by differences in the complement of X not Y genes. Dev Neurobiol 2008, 68:265-273.
38. Schoenwolf GC. Histological and ultrastructural studies of secondary neurulation of mouse embryos. Am J Anat 1984, 169:361-374.
39. Lemire RJ. Variations in development of the caudal neural tube in human embryos (horizons XIV-XXI). Teratology 1969, 2:361-370.
40. Cambray N, Wilson V. Axial progenitors with extensive potency are localised to the mouse chordoneural hinge. Development 2002, 129:4855-4866.
41. Copp AJ, Checiu I, Henson JN. Developmental basis of severe neural tube defects in the loop-tail (Lp) mutant mouse: use of microsatellite DNA markers to identify embryonic genotype. Dev Biol 1994, 165:20-29.
42. Ybot-Gonzalez P, Gaston-Massuet C, Girdler G, Klingensmith J, Arkell R, Greene ND, Copp AJ. Neural plate morphogenesis during mouse neurulation is regulated by antagonism of BMP signalling. Development 2007, 134:3203-3211.
43. Ybot-Gonzalez P, Savery D, Gerrelli D, Signore M, Mitchell CE, Faux CH, Greene NDE, Copp AJ. Convergent extension, planar-cell-polarity signalling and initiation of mouse neural tube closure. Development 2007, 134:789-799.
44. Keller R, Shook D, Skoglund P. The forces that shape embryos: physical aspects of convergent extension by cell intercalation. Phys Biol 2008, 5:15007.
45. Montcouquiol M, Crenshaw EB III, Kelley MW. Noncanonical Wnt signaling and neural polarity. Annu Rev Neurosci 2006, 29:363-386.
46. Wallingford JB, Harland RM. Neural tube closure requires dishevelled-dependent convergent extension of the midline. Development 2002, 129:5815-5825.
47. Greene NDE, Gerrelli D, Van Straaten HWM, Copp AJ. Abnormalities of floor plate, notochord and somite differentiation in the loop-tail (Lp) mouse: a model of severe neural tube defects. Mech Dev 1998, 73:59-72.
48. Murdoch JN, Copp AJ. The relationship between Hedgehog signalling, cilia and neural tube defects. Birth Defects Res A Clin Mol Teratol 2010, 88:633-652.
49. Chiang C, Litingtung Y, Lee E, Young KE, Corden JL, Westphal H, Beachy PA. Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature 1996, 383:407-413.
50. Zhang XM, Ramalho-Santos M, McMahon AP. Smoothened mutants reveal redundant roles for Shh and Ihh signaling including regulation of L/R asymmetry by the mouse node. Cell 2001, 105:781-792.
51. Ybot-Gonzalez P, Cogram P, Gerrelli D, Copp AJ. Sonic hedgehog and the molecular regulation of neural tube closure. Development 2002, 129:2507-2517.
52. Brook FA, Shum ASW, Van Straaten HWM, Copp AJ. Curvature of the caudal region is responsible for failure of neural tube closure in the curly tail (ct) mouse embryo. Development 1991, 113:671-678.
53. Ting SB, Wilanowski T, Auden A, Hall M, Voss AK, Thomas T, Parekh V, Cunningham JM, Jane SM. Inositol- and folate-resistant neural tube defects in mice lacking the epithelial-specific factor Grhl-3. Nat Med 2003, 9:1513-1519.
54. Gustavsson P, Greene ND, Lad D, Pauws E, de Castro SC, Stanier P, Copp AJ. Increased expression of Grainyhead-like-3 rescues spina bifida in a folate-resistant mouse model. Hum Mol Genet 2007, 16: 2640-2646.
55. Brouns MR, de Castro SC, Terwindt-Rouwenhorst EA, Massa V, Hekking JW, HIrst CS, Savery D, Munts C, Partridge D, Lamers W, et al. Over-expression of Grhl2 causes spina bifida in the axial defects mutant mouse. Hum Mol Genet 2011, 20:1536-1546.
56. Pennimpede T, Cameron DA, MacLean GA, Li H, Abu-Abed S, Petkovich M. The role of CYP26 enzymes in defining appropriate retinoic acid exposure during embryogenesis. Birth Defects Res A Clin Mol Teratol 2010, 88:883-894.
57. Sadler TW, Greenberg D, Coughlin P, Lessard JL. Actin distribution patterns in the mouse neural tube during neurulation. Science 1982, 215:172-174.
58. Morriss-Kay GM, Tuckett F. The role of microfilaments in cranial neurulation in rat embryos: effects of short-term exposure to cytochalasin D. J Embryol Exp Morphol 1985, 88:333-348.
59. Ybot-Gonzalez P, Copp AJ. Bending of the neural plate during mouse spinal neurulation is independent of actin microfilaments. Dev Dyn 1999, 215:273-283.
60. Massa V, Savery D, Ybot-Gonzalez P, Ferraro E, Rongvaux A, Cecconi F, Flavell RA, Greene NDE, Copp AJ. Apoptosis is not required for mammalian neural tube closure. Proc Natl Acad Sci U S A 2009, 106: 8233-8238.
61. Kim TH, Goodman J, Anderson KV, Niswander L. Phactr4 regulates neural tube and optic fissure closure by controlling PP1-, Rb-, and E2F1-regulated cell-cycle progression. Dev Cell 2007, 13:87-102.
62. Lorber J. Results of treatment of myelomeningocele. An analysis of 524 unselected cases with special reference to possible selection for treatment. Dev Med Child Neurol 1971, 13:279-303.
63. Cameron M, Moran P. Prenatal screening and diagnosis of neural tube defects. Prenat Diagn 2009, 29:402-411.
64. Adzick NS, Thom EA, Spong CY, Brock JW III, Burrows PK, Johnson MP, Howell LJ, Farrell JA, Dabrowiak ME, Sutton LN, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 2011, 364:993-1004.
65. Grosse SD, Ouyang L, Collins JS, Green D, Dean JH, Stevenson RE. Economic evaluation of a neural tube defect recurrence-prevention program. Am J Prev Med 2008, 35:572-577.
66. Yi Y, Lindemann M, Colligs A, Snowball C. Economic burden of neural tube defects and impact of prevention with folic acid: a literature review. Eur J Pediatr 2011, 170:1391-1400.
67. Smithells RW, Sheppard S, Schorah CJ, Seller MJ, Nevin NC, Harris R, Read AP, Fielding DW. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 1980, 1:339-340.
68. Wald N, Sneddon J, Densem J, Frost C, Stone R, MRC Vitamin Study Res Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991, 338:131-137.
69. Eichholzer M, Tonz O, Zimmermann R. Folic acid: a public-health challenge. Lancet 2006, 367:1352-1361.
70. Heseker HB, Mason JB, Selhub J, Rosenberg IH, Jacques PF. Not all cases of neural-tube defect can be prevented by increasing the intake of folic acid. Br J Nutr 2008, 16:1-8.
71. 12 are independent risk factors for neural tube defects. Q J Med 1993, 86:703-708.
72. Cavalli P, Tedoldi S, Riboli B. Inositol supplementation in pregnancies at risk of apparently folate-resistant NTDs. Birth Defects Res A Clin Mol Teratol 2008, 82:540-542.
73. Greene ND, Copp AJ. Mouse models of neural tube defects: investigating preventive mechanisms. Am J Med Genet C Semin Med Genet 2005, 135:31-41.
74. Cockroft DL. Changes with gestational age in the nutritional requirements of postimplantation rat embryos in culture. Teratology 1988, 38:281-290.
75. Groenen PM, Peer PG, Wevers RA, Swinkels DW, Franke B, Mariman EC, Steegers-Theunissen RP. Maternal myo-inositol, glucose, and zinc status is associated with the risk of offspring with spina bifida. Am J Obstet Gynecol 2003, 189:1713-1719.
76. Wyszynski DF, ed. Neural Tube Defects: From Origin to Treatment. Oxford: Oxford University Press; 2006, 15-28.